PROMEDIOR

Promedior is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By specifically targeting these cells at the site of injury, Promedior is able to treat the source of aberrant immune system responses, promote tissue healing and resolution, an... d greatly reduce the risk of systemic side effects inherent in current therapeutic approaches. Promedior is developing drugs to address the most severe and difficult-to-treat fibrotic and inflammatory conditions of the eye, lung and kidney such as glaucoma, age-related macular degeneration, diabetic retinopathy and dry eye disease; pulmonary fibrosis, scleroderma and COPD; and acute and chronic nephropathy.

#SimilarOrganizations #People #Financial #Website #More

PROMEDIOR

Industry:

Biopharma Biotechnology Health Care Therapeutics

Founded:

2006-01-01

Address:

Lexington, Massachusetts, United States

Country:

United States

Website Url:

http://www.roche.com

Total Employee:

51+

Status:

Active

Contact:

781-538-4200

Email Addresses:

[email protected]

Total Funding:

63 M USD

Technology used in webpage:

Viewport Meta SPF Mobile Non Scaleable Content IPv6 Google Maps Microsoft Mimecast Akamai DNS

Similar Organizations

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

revision-therapeutics-logo

ReVision Therapeutics

ReVision Therapeutics, a biopharmaceutical company, develops drugs for the treatment of age-related macular degeneration diseases.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

Current Advisors List

geert-jan-mulder_image

Geert Jan Mulder Board of Directors @ Promedior
Board_member

not_available_image

Nancy K. Thomason Board of Directors @ Promedior
Board_member

john-h-friedman_image

John H. Friedman Board of Directors @ Promedior
Board_member

paul-d-goldenheim_image

Paul D. Goldenheim Board of Directors @ Promedior
Board_member

gus-lawlor_image

Gus Lawlor Board of Directors @ Promedior
Board_member

Current Employees Featured

mark-l-lupher-jr_image

MARK L. LUPHER, JR.
MARK L. LUPHER, JR. Chief Scientific Officer @ Promedior
Chief Scientific Officer

not_available_image

Richard Jack
Richard Jack Senior Scientific Consultant to Promedior, A Member of the Roche Group @ Promedior
Senior Scientific Consultant to Promedior, A Member of the Roche Group
2020-09-01

Founder

jim-broderick_image

Jim Broderick

Investors List

sofinnova-ventures_image

Official Site Inspections

http://www.roche.com Semrush global rank: 4.41 M Semrush visits lastest month: 959

Host Informations
Whois Informations

Loading ...